TORONTO (Reuters) - The Canadian government announced final regulations on Friday that should cut billions of dollars from patented drug prices that are among the highest in the world, overcoming heavy
The Canadian government has announced regulations to reduce patented drug prices it said would save Canadians C$13.2bn (US$10bn) over a decade, overriding heavy opposition from pharmaceutical companies.
The federal government has unveiled its long-awaited overhaul of the country’s drug-pricing regulations with a new framework that the Liberals say will save Canadians billions over the next decade. Under
OTTAWA — The federal government is overhauling the way it regulates the cost of patented medicines, including ending comparisons to the United States — changes that Canada’s health minister is billing